详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case report(Open Access)

118| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE ◇ SSCI

作者：

机构： [1]Department of Thoracic Surgery, Xuanwu Hospital, The Capital Medical University, Beijing, China. [2]Department of Pathology, Xuanwu Hospital, The Capital Medical University, Beijing, China

出处：

DOI：

ISSN：

关键词： Lung adenocarcinoma Ovarian metastasis Debulking surgery Targeted therapy Case report

摘要：

Background: Lung adenocarcinoma which invades ovaries is very rare. However, with the increase of long-survival female lung cancer, more patients will suffer ovarian metastasis. On grounds of the paucity of reported cases, the clinicopathological features and treatment strategies remain unknown. Case presentation: This patient was stage IV lung adenocarcinoma at first diagnosis. Following multiple-line systemic treatments, she experienced extensive pelvic metastasis. After debulking surgery and reevaluation about the drive genes, she was administered by targeted therapy. Up to now, the patient has shown no evidence of progression for 8 years after the initial diagnosis of primary lung cancer and 46 months after her ovarian metastasis. Conclusion: The comprehensive treatment modality for the bilateral ovarian metastasis is effective in clinical course. © 2021, The Author(s).

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 4 区医学

小类 | 4 区妇产科学

最新[2025]版：

大类 | 3 区医学

小类 | 3 区妇产科学 3 区公共卫生、环境卫生与职业卫生

JCR分区：

出版当年[2019]版：

Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Q4 OBSTETRICS & GYNECOLOGY

最新[2023]版：

Q2 OBSTETRICS & GYNECOLOGY Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

影响因子： 2.4 最新[2023版] 2.9 最新五年平均 1.544 出版当年[2019版] 2.205 出版当年五年平均 1.592 出版前一年[2018版] 2.809 出版后一年[2020版]

第一作者：

第一作者机构： [1]Department of Thoracic Surgery, Xuanwu Hospital, The Capital Medical University, Beijing, China.

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]最大径≤1 cm的纯磨玻璃密度肺腺癌病理分类及CT征象特点分析 [2]Recurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features [3]Durable response to immunotherapy plus chemotherapy in a patient with untreated, brain-metastatic, EGFR exon 20 insertion mutation lung adenocarcinoma A case report [4]Recent Advances in Targeted Therapy for Glioma. [5]Integrative Proteomic Characterization of Human Lung Adenocarcinoma [6]Chemical Conjugation Of Evans Blue Derivative Prolongs Blood Half-life And Improves The Integrin alpha(V)beta(3)-targeted (177)lu-radionuclide Therapy In A Patient-derived Xenograft Model Of Lung Adenocarcinoma [7]Lung adenocarcinoma metastasizing to cerebellopontine angle schwannoma (collision tumor) [8]Elevated SRC3 expression predicts pemetrexed resistance in lung adenocarcinoma. [9]Endoglin (CD105) expression and angiogenesis status in invasive lung adenocarcinoma [10]HSG-MLF1IP axis as potential targets for lung adenocarcinoma treatment.